BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 31111910)

  • 21. Antifungal susceptibility profile of invasive
    Memon S; Farooqi J; Zafar U; Naqvi SF; Zafar A; Jabeen K
    J Med Microbiol; 2021 Dec; 70(12):. PubMed ID: 34878377
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro antifungal susceptibilities of Candida isolates from patients with invasive candidiasis in Kuala Lumpur Hospital, Malaysia.
    Amran F; Aziz MN; Ibrahim HM; Atiqah NH; Parameswari S; Hafiza MR; Ifwat M
    J Med Microbiol; 2011 Sep; 60(Pt 9):1312-1316. PubMed ID: 21459913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative in vitro activities of seven antifungal drugs against clinical isolates of Candida parapsilosis complex.
    Khodavaisy S; Badali H; Meis JF; Modiri M; Mahmoudi S; Abtahi H; Salehi M; Dehghan Manshadi SA; Aala F; Agha Kuchak Afshari S; Lotfali E; Ahangarkani F; Rezaie S
    J Mycol Med; 2020 Sep; 30(3):100968. PubMed ID: 32386800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasive candidiasis in Pakistan: clinical characteristics, species distribution and antifungal susceptibility.
    Farooqi JQ; Jabeen K; Saeed N; Iqbal N; Malik B; Lockhart SR; Zafar A; Brandt ME; Hasan R
    J Med Microbiol; 2013 Feb; 62(Pt 2):259-268. PubMed ID: 23105021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five-Year National Surveillance of Invasive Candidiasis: Species Distribution and Azole Susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study.
    Xiao M; Sun ZY; Kang M; Guo DW; Liao K; Chen SC; Kong F; Fan X; Cheng JW; Hou X; Zhou ML; Li Y; Yu SY; Huang JJ; Wang H; Xu YC;
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging Candida species isolated from renal transplant recipients: Species distribution and susceptibility profiles.
    Diba K; Makhdoomi K; Nasri E; Vaezi A; Javidnia J; Gharabagh DJ; Jazani NH; Reza Chavshin A; Badiee P; Badali H; Fakhim H
    Microb Pathog; 2018 Dec; 125():240-245. PubMed ID: 30240817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species,
    Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E
    Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
    Lindberg E; Hammarström H; Ataollahy N; Kondori N
    Sci Rep; 2019 Mar; 9(1):3838. PubMed ID: 30846717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study.
    Liu W; Tan J; Sun J; Xu Z; Li M; Yang Q; Shao H; Zhang L; Liu W; Wan Z; Cui W; Zang B; Jiang D; Fang Q; Qin B; Qin T; Li W; Guo F; Liu D; Guan X; Yu K; Qiu H; Li R;
    J Antimicrob Chemother; 2014 Jan; 69(1):162-7. PubMed ID: 24004860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.
    Wang H; Xu YC; Hsueh PR
    Future Microbiol; 2016 Oct; 11():1461-1477. PubMed ID: 27750452
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Quindós G; Miranda-Cadena K; San-Millán R; Borroto-Esoda K; Cantón E; Linares-Sicilia MJ; Hamprecht A; Montesinos I; Tortorano AM; Prigitano A; Vidal-García M; Marcos-Arias C; Guridi A; Sanchez-Reus F; Machuca-Bárcena J; Rodríguez-Iglesias MA; Martín-Mazuelos E; Castro-Méndez C; López-Soria L; Ruiz-Gaitán A; Fernandez-Rivero M; Lorenzo D; Capilla J; Rezusta A; Pemán J; Guarro J; Pereira J; Pais C; Romeo O; Ezpeleta G; Jauregizar N; Angulo D; Eraso E
    Front Cell Infect Microbiol; 2022; 12():906563. PubMed ID: 35651755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
    Rubio Calvo MC; Gil J; Ramírez de Ocáriz I; Benito R; Rezusta A
    Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.
    Miranda-Zapico I; Eraso E; Hernández-Almaraz JL; López-Soria LM; Carrillo-Muñoz AJ; Hernández-Molina JM; Quindós G
    J Antimicrob Chemother; 2011 Oct; 66(10):2315-22. PubMed ID: 21795259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifungal susceptibility testing of a 10-year collection of Candida spp. isolated from patients with candidemia.
    Iatta R; Caggiano G; Cuna T; Montagna MT
    J Chemother; 2011 Apr; 23(2):92-6. PubMed ID: 21571625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative evaluation of a new commercial colorimetric microdilution assay (SensiQuattro Candida EU) with MIC test strip and EUCAST broth microdilution methods for susceptibility testing of invasive Candida isolates.
    Koehling HL; Willinger B; Buer J; Rath PM; Steinmann J
    J Clin Microbiol; 2015 Jan; 53(1):255-61. PubMed ID: 25392352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Candida infection in the intensive care unit: A study of antifungal susceptibility pattern of Candida species in Milad hospital, Tehran, Iran.
    Alimehr S; Shekari Ebrahim Abad H; Fallah F; Rahbar M; Mohammadzadeh M; Vossoghian S; Rafeei Tabatabaee S; Roudbary M; Zaini F
    J Mycol Med; 2015 Dec; 25(4):e113-7. PubMed ID: 26563641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.
    Diekema DJ; Messer SA; Boyken LB; Hollis RJ; Kroeger J; Tendolkar S; Pfaller MA
    J Clin Microbiol; 2009 Oct; 47(10):3170-7. PubMed ID: 19710283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
    Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F
    Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rezafungin
    Helleberg M; Jørgensen KM; Hare RK; Datcu R; Chowdhary A; Arendrup MC
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifungal susceptibility of Candida species isolated from patients with candidemia in southern Taiwan, 2007-2012: impact of new antifungal breakpoints.
    Chen YC; Kuo SF; Chen FJ; Lee CH
    Mycoses; 2017 Feb; 60(2):89-95. PubMed ID: 27621210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.